Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood
- PMID: 10206124
- DOI: 10.1007/s004310051073
Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood
Abstract
A 12-year-old boy with tuberous sclerosis complex (TSC) presented with a large retroperitoneal tumour. Exploratory surgery revealed an infiltrative tumour originating from the pancreas, with local metastases to the lymph nodes. The histologal diagnosis was a malignant islet cell tumour. Retrospectively measured pancreatic hormone levels, however, were normal. A connection between the malignancy and TSC was demonstrated by loss of heterozygosity of the TSC2 gene in the tumour. The primary mutation Q478X in this patient was identified in exon 13 of the TSC2 gene on chromosome 16.
Conclusion: Pancreatic islet cell tumours have been mainly associated with multiple endocrine neoplasia syndrome type 1. In our case we demonstrate a direct relationship of this tumour to tuberous sclerosis complex, in the absence of further signs of multiple endocrine neoplasia syndrome type 1.
Similar articles
-
Malignant pancreatic endocrine tumor in a child with tuberous sclerosis.Am J Surg Pathol. 2003 Oct;27(10):1386-9. doi: 10.1097/00000478-200310000-00012. Am J Surg Pathol. 2003. PMID: 14508401
-
Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature.Am J Surg Pathol. 2012 Jan;36(1):149-53. doi: 10.1097/PAS.0b013e31823d0560. Am J Surg Pathol. 2012. PMID: 22173120 Review.
-
Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations.Am J Med Genet A. 2006 Aug 1;140(15):1669-72. doi: 10.1002/ajmg.a.31351. Am J Med Genet A. 2006. PMID: 16835931
-
Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.Pediatr Radiol. 2015 Mar;45(3):386-95. doi: 10.1007/s00247-014-3147-1. Epub 2014 Oct 30. Pediatr Radiol. 2015. PMID: 25355409
-
Tuberous sclerosis gene products in proliferation control.Mutat Res. 2001 Jul;488(3):233-9. doi: 10.1016/s1383-5742(01)00058-8. Mutat Res. 2001. PMID: 11397651 Review.
Cited by
-
Novel classification based on immunohistochemistry combined with hierarchical clustering analysis in non-functioning neuroendocrine tumor patients.Cancer Sci. 2010 Oct;101(10):2278-85. doi: 10.1111/j.1349-7006.2010.01657.x. Epub 2010 Aug 2. Cancer Sci. 2010. PMID: 20682006 Free PMC article.
-
Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.Virchows Arch. 2023 Aug;483(2):167-175. doi: 10.1007/s00428-023-03570-1. Epub 2023 Jun 24. Virchows Arch. 2023. PMID: 37354253
-
Malignant tumors in tuberous sclerosis complex: a case report and review of the literature.BMC Med Genomics. 2024 May 27;17(1):144. doi: 10.1186/s12920-024-01913-8. BMC Med Genomics. 2024. PMID: 38802873 Free PMC article. Review.
-
Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports.Front Neurol. 2021 Apr 9;12:627672. doi: 10.3389/fneur.2021.627672. eCollection 2021. Front Neurol. 2021. PMID: 33897589 Free PMC article.
-
Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.Clin Med Insights Oncol. 2012;6:41-51. doi: 10.4137/CMO.S7319. Epub 2012 Jan 4. Clin Med Insights Oncol. 2012. PMID: 22253554 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical